This is a prospective, single-center, exploratory study designed to evaluate the accuracy, user engagement, and user experience of the BaiXiaoAi Companion AI. Upon signing the informed consent form and enrollment, a dedicated "Doctor-Nurse-Patient-AI" WeChat group will be established for each participant. Within the group, the BaiXiaoAi AI will provide timely responses based on patient communications and proactively push information regarding disease management and patient education.
Adults aged 18 years or older;
Patients with a confirmed diagnosis of malignant neoplasms who are currently undergoing treatment or in follow-up, or their primary caregivers;
Able to read and communicate in Chinese and independently use WeChat;
Willing and able to provide informed consent.
Presence of severe psychiatric disorders (e.g., schizophrenia, bipolar disorder) or cognitive impairment (MMSE score < 24);
Inability to use WeChat or communicate in Chinese;
Considered by the investigators to be unsuitable for participation due to psychological or physical conditions.
Adult patients diagnosed with malignant neoplasms who are undergoing cancer treatment or follow-up at a single study center, as well as their primary caregivers. Participants are enrolled after providing informed consent and are followed prospectively for observational data collection related to communication needs and usage patterns during routine care.
Cohort
Prospective
No Intervention: Observational Cohort
Other interventionThis is an observational study. No experimental intervention (including drugs, devices, etc.) will be administered to the participants. The investigators will only collect clinical data and follow-up outcomes of the participants according to the study protocol.
Accuracy and safety of AI-assisted patient communication
The accuracy and safety of the AI-assisted communication tool will be assessed by monitoring the occurrence and severity of AI-related safety events during the study period. Safety events include misinformation, misunderstanding, inappropriate emotional responses, or potential risks related to medical decision-making attributable to the AI tool. Events are classified into four levels (Grade 0-3), where Grade 0 indicates no issue and Grade 3 indicates a serious error with potential medical risk.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
